Long‐term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls

Long‐term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls

Abstract In this analysis, we examined the risk of secondary malignancies for tyrosine kinase inhibitor (TKI) therapy in chronic myeloid leukemia (CML) patients. We also collected data on specific risk factors for colorectal cancer. Ninety‐one patients with CML and 76 controls were included and in t...

Full description

Bibliographic Details
Main Authors: Nina Winkelmann, Michaela Schwarz, Bert Hildebrandt, Oliver Henke, Lars Bullinger, Il‐Kang Na, Sebastian Stintzing, Philipp le Coutre
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:eJHaem
Subjects:
chronic myeloid leukemia
colorectal cancer
secondary malignancy
Online Access:https://doi.org/10.1002/jha2.502

Internet

https://doi.org/10.1002/jha2.502

Similar Items